Kubota Pharmaceutical Holdings Co., Ltd. Logo

Kubota Pharmaceutical Holdings Co., Ltd.

Developing ophthalmic drugs and devices to preserve and restore vision for patients globally.

4596 | T

Overview

Corporate Details

ISIN(s):
JP3266500002
LEI:
Country:
Japan
Address:
千代田区霞が関3丁目7番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Kubota Pharmaceutical Holdings Co., Ltd. is a holding company dedicated to developing and commercializing a diverse portfolio of drugs and devices to address sight-threatening ophthalmic diseases. Operating through its subsidiary, Kubota Vision Inc., the company's mission is to find cures for blindness and to preserve and restore vision for patients globally. Its pipeline includes pharmaceutical candidates and innovative medical devices, such as the "Kubota Glass®" wearable technology. The company focuses on translating scientific innovation into tangible therapeutic solutions through research, development, and global commercialization partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-17 01:00
Registration Form
有価証券届出書(組込方式)
Japanese 351.3 KB
2025-08-14 08:30
Regulatory News Service
確認書
Japanese 8.4 KB
2025-08-14 08:30
Interim Report
半期報告書-第11期(2025/01/01-2025/12/31)
Japanese 230.5 KB
2025-07-31 08:37
Share Issue/Capital Change
訂正臨時報告書
Japanese 35.5 KB
2025-07-16 08:30
Share Issue/Capital Change
臨時報告書
Japanese 40.1 KB
2025-06-30 08:37
Share Issue/Capital Change
訂正臨時報告書
Japanese 28.6 KB
2025-06-20 08:30
Share Issue/Capital Change
臨時報告書
Japanese 27.5 KB
2025-04-21 08:30
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2025-03-28 08:10
Registration Form
確認書
Japanese 8.4 KB
2025-03-28 08:09
Annual Report
有価証券報告書-第10期(2024/01/01-2024/12/31)
Japanese 945.2 KB
2025-03-28 08:09
Governance Information
内部統制報告書-第10期(2024/01/01-2024/12/31)
Japanese 22.6 KB
2024-08-20 08:11
Registration Form
有価証券届出書(組込方式)
Japanese 231.3 KB
2024-08-14 08:03
Report Publication Announcement
確認書
Japanese 8.5 KB
2024-08-14 08:02
Interim Report
半期報告書-第10期(2024/01/01-2024/12/31)
Japanese 208.9 KB
2024-05-14 08:01
Regulatory News Service
確認書
Japanese 8.3 KB

Automate Your Workflow. Get a real-time feed of all Kubota Pharmaceutical Holdings Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kubota Pharmaceutical Holdings Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kubota Pharmaceutical Holdings Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.